Company intelligence / Profile preview
LivFul
Alpharetta, Georgia, United Stateslivful.com ↗
- Ownership
- Private
- Employees
- ~36
- Development stage
- Commercial
01
Overview
LivFul has demonstrated anti-tumor activity in animal models for its oncology programs. Its STAYTEC™ repellent has been developed specifically for challenging environments in the global south to prevent malaria and other vector-borne diseases.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small moleculeDeviceBiologic
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Partners with local health systems across developing countriesout-license to global pharmaceutical partnerspublic/private partnerships for distribution in the global south
Beyond the preview
Go deeper on LivFul.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LivFul.